Cathie Wood’s ARK Invest Sells 3.6 Million Shares of Syros Pharma
One of Cathie Wood's Ark Invest funds sold nearly 3.6 million shares of Syros Pharma on May 26.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold nearly 3.6 million shares of Syros Pharmaceuticals Inc. (NASDAQ: SYRS) on Wednesday, as the share price of this fund traded up nearly 2% in the day’s session. The fund’s share price has greatly improved over the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 3,574,908 shares of Syros Pharma. At Wednesday’s closing price, this would have valued this sale at roughly $20.0 million. This is only a small fraction of the total holdings. ARKK is up 81% over the past 52 weeks.
Here is a quick look at all the other sales that took place across all ARK ETFs:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE CO LTD | 677,300 |
| ARKF | GWRE | GUIDEWIRE SOFTWARE INC | 246 |
| ARKG | GH | GUARDANT HEALTH INC | 10,800 |
| ARKG | NVS | NOVARTIS AG | 166,980 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS INC | 50,671 |
| ARKG | TAK | TAKEDA PHARMACEUTICAL CO LTD | 78,202 |
| ARKK | SYRS | SYROS PHARMACEUTICALS INC | 3,574,908 |
| ARKK | ONVO | ORGANOVO HOLDINGS INC | 8,989 |
| ARKK | HUYA | HUYA INC | 486,140 |
| ARKQ | AVAV | AEROVIRONMENT INC | 11,207 |
| ARKQ | GLEO | GALILEO ACQUISITION CORP | 22,423 |
| ARKQ | ADSK | AUTODESK INC | 119 |
| ARKX | RAVN | RAVEN INDUSTRIES INC | 9,215 |
| ARKX | ADSK | AUTODESK INC | 23 |
| ARKX | WKHS | WORKHORSE GROUP INC | 6 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
